Watchlist Price Alert

Silexion Therapeutics LTD (SLXN)

NASDAQ: SLXN · Real-Time Price · USD

0.93

0.01 (0.92%)

At close: Jun 06, 2025, 3:59 PM

0.93

-0.10%

After-hours: Jun 06, 2025, 05:24 PM EDT

Silexion Therapeutics LTD Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Cash & Equivalents	6.15M	1.19M	1.97M	1.7M	2.78M	108.28K	58.24K	34.53K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	5.7M	5.58M	27.4M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	52K	53K	5K	30K	30K	30K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.57M	97K	130K	91K	93K	49K	n/a	n/a
Total Current Assets	7.72M	2.25M	3.05M	2.31M	3.34M	4.98M	5.67M	27.48M
Property-Plant & Equipment	534K	560K	35K	180K	216K	247K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	586K	613K	40K	210K	246K	277K	n/a	n/a
Total Assets	8.31M	2.86M	3.09M	2.52M	3.58M	5.26M	5.67M	27.48M
Account Payables	n/a	929K	799K	281K	244K	319K	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	155K	1M	229K	n/a	n/a	2.86M	2.49M	2.11M
Other Current Liabilities	2.24M	644K	697K	596K	535K	115.56K	34.23K	131.68K
Total Current Liabilities	2.4M	3.52M	3.58M	2.36M	1.94M	2.2M	2.53M	2.24M
Long-Term Debt	334K	2.96M	4.08M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	2.99M	n/a	n/a	15.06M	15.06M	15.06M	9.4K	24.34K
Total Long-Term Liabilities	3.33M	3.33M	4.08M	15.06M	15.09M	15.12M	9.4K	24.34K
Total Liabilities	5.72M	6.85M	7.67M	17.43M	17.03M	17.31M	2.53M	2.27M
Total Debt	489K	4.49M	4.31M	116K	144K	171K	2.49M	2.11M
Common Stock	9K	2K	1K	1K	1K	1K	5.58M	27.41M
Retained Earnings	-44.99M	-43.25M	-41.58M	-29.66M	-28.18M	-26.81M	-2.45M	-2.19M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	2.59M	-3.99M	-4.58M	-18.26M	-16.82M	-15.48M	3.14M	25.22M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	5.58M	27.4M